Gentian Diagnostics ASA (OSL:GENT)
Norway · Delayed Price · Currency is NOK 59.00
+1.60 (2.79%)
At close: Jan 13, 2026
Gentian Diagnostics ASA Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 909.92 million as of January 13, 2026. Its market cap has increased by 51.28% in one year.
Market Cap
909.92M
Enterprise Value
825.20M
Revenue
172.52M
Ranking
n/a
PE Ratio
21.45
Stock Price
59.00
Market Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 909.92M, an increase of 214.18%. That is a compound annual growth rate of 13.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 909.92M | 4.61% |
| Dec 30, 2025 | 869.82M | 43.88% |
| Dec 30, 2024 | 604.56M | -5.54% |
| Dec 29, 2023 | 640.03M | 1.22% |
| Dec 30, 2022 | 632.32M | -43.06% |
| Dec 30, 2021 | 1.11B | 32.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.74B |
| Nordhealth AS | 2.83B |
| Photocure ASA | 2.02B |
| Thor Medical ASA | 1.83B |
| ArcticZymes Technologies ASA | 1.25B |
| Omda AS | 982.32M |
| Vistin Pharma ASA | 931.24M |
| Nykode Therapeutics AS | 745.18M |